These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

71 related items for PubMed ID: 9480313

  • 1. [Emerging infectious and drug-resistant diseases--vancomycin resistant gram-positive cocci].
    Hanaki H, Hiramatsu K.
    Nihon Naika Gakkai Zasshi; 1997 Nov 10; 86(11):2075-80. PubMed ID: 9480313
    [No Abstract] [Full Text] [Related]

  • 2. [Surveillance on gram-positive bacteria isolated from patients with hospital acquired infections or community acquired infections].
    Li JT, Li Y, Wang J, China Bacterial Resistance Surveillance Study Group.
    Zhonghua Yi Xue Za Zhi; 2003 Mar 10; 83(5):365-74. PubMed ID: 12820911
    [Abstract] [Full Text] [Related]

  • 3. Vancomycin resistance in gram-positive cocci.
    Courvalin P.
    Clin Infect Dis; 2006 Jan 01; 42 Suppl 1():S25-34. PubMed ID: 16323116
    [Abstract] [Full Text] [Related]

  • 4. Antimicrobial susceptibility of Gram-positive bacterial isolates from the Asia-Pacific region and an in vitro evaluation of the bactericidal activity of daptomycin, vancomycin, and teicoplanin: a SENTRY Program Report (2003-2004).
    Biedenbach DJ, Bell JM, Sader HS, Fritsche TR, Jones RN, Turnidge JD.
    Int J Antimicrob Agents; 2007 Aug 01; 30(2):143-9. PubMed ID: 17531446
    [Abstract] [Full Text] [Related]

  • 5. [In vitro activity of vancomycin and teicoplanin against gram-positive cocci].
    Bezian MC, Ribou G, Masquelier B.
    Pathol Biol (Paris); 1992 May 01; 40(5):461-5. PubMed ID: 1386667
    [Abstract] [Full Text] [Related]

  • 6. [Nosocomial catheter-related sepsis secondary to central venous catheters].
    Wu H, Wu Z, Jin D, Xu J.
    Zhonghua Wai Ke Za Zhi; 1999 Nov 01; 37(11):651-3. PubMed ID: 11829916
    [Abstract] [Full Text] [Related]

  • 7. Activity of vancomycin against recently isolated nosocomial gram-positive cocci.
    Maccanti O, Bonadio M.
    Drugs Exp Clin Res; 1992 Nov 01; 18(7):295-7. PubMed ID: 1295722
    [Abstract] [Full Text] [Related]

  • 8. Vancomycin resistance in gram-positive cocci--old bugs, new tricks, confusing terminology.
    Jones AR, Venkatesh B, Lipman J.
    Anaesth Intensive Care; 1999 Aug 01; 27(4):396-9. PubMed ID: 10470396
    [No Abstract] [Full Text] [Related]

  • 9. Current challenges in antibiotic resistance.
    Hand WL.
    Adolesc Med; 2000 Jun 01; 11(2):427-38. PubMed ID: 10916132
    [Abstract] [Full Text] [Related]

  • 10. [Infections of vancomycin resistant enterococci (VRE) and Staphylococcus aureus (VRSA)].
    Kuwahara K, Hanaki H, Hiramatsu K.
    Ryoikibetsu Shokogun Shirizu; 1999 Jun 01; (23 Pt 1):182-5. PubMed ID: 10088368
    [No Abstract] [Full Text] [Related]

  • 11. Comparative bactericidal activities of daptomycin, glycopeptides, linezolid and tigecycline against blood isolates of Gram-positive bacteria in Taiwan.
    Huang YT, Liao CH, Teng LJ, Hsueh PR.
    Clin Microbiol Infect; 2008 Feb 01; 14(2):124-9. PubMed ID: 18076671
    [Abstract] [Full Text] [Related]

  • 12. Frequency of reduced vancomycin susceptibility and heterogeneous subpopulation in persistent or recurrent methicillin-resistant Staphylococcus aureus bacteremia.
    Khosrovaneh A, Riederer K, Saeed S, Tabriz MS, Shah AR, Hanna MM, Sharma M, Johnson LB, Fakih MG, Khatib R.
    Clin Infect Dis; 2004 May 01; 38(9):1328-30. PubMed ID: 15127350
    [Abstract] [Full Text] [Related]

  • 13. Antibacterial activity of linezolid and vancomycin in an in vitro pharmacodynamic model of gram-positive catheter-related bacteraemia.
    Wiederhold NP, Coyle EA, Raad II, Prince RA, Lewis RE.
    J Antimicrob Chemother; 2005 May 01; 55(5):792-5. PubMed ID: 15814598
    [Abstract] [Full Text] [Related]

  • 14. Reduced susceptibility of Staphylococcus aureus to vancomycin--Japan, 1996.
    Centers for Disease Control and Prevention (CDC).
    MMWR Morb Mortal Wkly Rep; 1997 Jul 11; 46(27):624-6. PubMed ID: 9218648
    [Abstract] [Full Text] [Related]

  • 15. Nosocomial methicillin--resistant Staphylococcus aureus with reduced susceptibility to vancomycin.
    Bhat G, Kamath S, Hussain A.
    Indian J Pathol Microbiol; 2006 Apr 11; 49(2):311-2. PubMed ID: 16933753
    [No Abstract] [Full Text] [Related]

  • 16. Seeking vancomycin resistant Staphylococcus aureus among patients with vancomycin-resistant enterococci.
    Franchi D, Climo MW, Wong AH, Edmond MB, Wenzel RP.
    Clin Infect Dis; 1999 Dec 11; 29(6):1566-8. PubMed ID: 10585815
    [Abstract] [Full Text] [Related]

  • 17. Evaluation of the extracellular and intracellular activities (human THP-1 macrophages) of telavancin versus vancomycin against methicillin-susceptible, methicillin-resistant, vancomycin-intermediate and vancomycin-resistant Staphylococcus aureus.
    Barcia-Macay M, Lemaire S, Mingeot-Leclercq MP, Tulkens PM, Van Bambeke F.
    J Antimicrob Chemother; 2006 Dec 11; 58(6):1177-84. PubMed ID: 17062609
    [Abstract] [Full Text] [Related]

  • 18. In vitro susceptibility of clinical isolates of methicillin-resistant Staphylococcus aureus (MRSA) to manufactured generic drugs compared with the brand vancomycin.
    Fujimura S, Watanabe A, Fuse K, Kikuchi T, Gomi K, Tokue Y.
    Int J Antimicrob Agents; 2008 Apr 11; 31(4):391-2. PubMed ID: 18308516
    [No Abstract] [Full Text] [Related]

  • 19. [Gram-positive, catalase negative cocci isolated from clinical material--identification and drug sensitivity of strains].
    Rokosz A, Rafałowska K, Lipnicki D.
    Przegl Epidemiol; 1996 Apr 11; 50(3):265-72. PubMed ID: 8927737
    [Abstract] [Full Text] [Related]

  • 20. Occurrence and mechanisms of glycopeptide resistance in gram-positive cocci.
    Saha V, Gupta S, Daum RS.
    Infect Agents Dis; 1992 Dec 11; 1(6):310-8. PubMed ID: 1344669
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.